Dr Sam Jackson
Sam leads our programmes on disease models, efficacy and safety pharmacology. He is a member of the Innovation and Translation Group.
For publications, see Sam's ResearchGate profile.
University College London, 2000-2004
Cannabinoids and neuroprotection in in vivo and in vitro models of multiple sclerosis.
University of Manchester, 1999-2000